Three FDA-approved GLP-1 medications are eligible under the bridge program when used to reduce excess body weight and maintain weight reduction: Wegovy (semaglutide), available as a weekly injection or daily oral tablet, manufactured by Novo Nordisk Zepbound (tirzepatide), available in the KwikPen autoinjector format, manufactured by Eli Lilly Foundayo (orforglipron), the first non-peptide, small-molecule oral GLP-1 for weight loss, recently FDA-approved and manufactured by Eli Lilly Each of these medications works by mimicking the activity of glucagon-like peptide-1, a hormone that regulates appetite, fullness, and blood sugar
COMPREHENSIVE 6-IN-1 SUPPORT FOR MODERN WEIGHT MANAGEMENT*: Supports GLP-1 activity, blood glucose, appetite, metabolism, gut health, and immune function-all in one streamlined formula.* Designed for those pursuing weight loss, enhancing GLP-1 activity naturally, complementing GLP-1 medications, or seeking a non-drug alternative, with an easy-to-integrate daily capsule routine
Probiotics for Cough & Congestion
Find a Wellstar urologist near you
Though stimulants like Vyvanse can sometimes be used off-label for conditions like extreme tiredness or cognitive challenges in neurological disorders, Vyvanse might be less likely to be used this way than other stimulants because of how it is metabolized
In controlled laboratory conditions, it may be included in experimental studies examining peptide stability, receptor affinity, and molecular interaction behavior
